Global Wearable Injectors Market: Almost 41% Of the Market’s Growth Will Originate From North America During 2020-2024

LONDON–(BUSINESS WIRE)–#GlobalWearableInjectorsMarket–The wearable injectors market is poised to grow by USD 4.12 billion during 2020-2024 progressing at a CAGR of almost 11% during the forecast period.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis

The report on the wearable injectors market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by demand for self-administrative drug delivery devices.

The wearable injectors market analysis includes product segment and geography landscape. This study identifies the technological advancements in wearable injectors as one of the prime reasons driving the wearable injectors market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters

The wearable injectors market covers the following areas:

Wearable Injectors Market Sizing

Wearable Injectors Market Forecast

Wearable Injectors Market Analysis

Companies Mentioned

• Amgen Inc. (Read more…)
• Becton
• Dickinson and Co.
• Enable Injections Inc.
• Gerresheimer AG
• Insulet Corp.
• Medtronic Plc
• Tandem Diabetes Care Inc.
• Valeritas Inc.
• West Pharmaceutical Services Inc.
• Ypsomed AG

   

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• On-body wearable injectors – Market size and forecast 2019-2024
• Off-body wearable injectors – Market size and forecast 2019-2024
• Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Technological advancements in wearable injectors
• Increasing number of partnerships and collaborations
• Increasing focus on development of biologics

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Amgen Inc.
• Becton, Dickinson and Co.
• Enable Injections, Inc.
• Gerresheimer AG
• Insulet Corp.
• Medtronic Plc
• Tandem Diabetes Care Inc.
• Valeritas Inc.
• West Pharmaceutical Services Inc.
• Ypsomed AG

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]
Website: www.technavio.com/